Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win

Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win

Submitted by admin on October 5, 2022 - 7:11pm
Source: 
Fierce Biotech
News Tags: 
Novo Nordisk
FDA
diabetes
insulin
basal insulin
Icodec
Headline: 
Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win
snippet: 

Novo Nordisk added the final piece to the puzzle the Danish drugmaker wanted to complete before submitting its once-weekly insulin icodec to regulators next year.

Do Not Allow Advertisers to Use My Personal information